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Three human monoclonal rheumatoid factor (mRF) crossidiotype (XId)
groups, WA, PO, and BLA, were defined using polyclonal antisera (1, 2). Both
the WA and the BLA XIdsappeared to be associated with the antigen-combining
site (2), and serologic studies (3, 4) indicated that the antisera defining the WA
XId appeared to recognize a determinant requiring both H and L chains.
Structural characterization ofthe Ids was not done. Extensive studies (5-7) have
recently been performed, however, to determine the structural basis of the WA
XId. Investigators using antisera to primary structures on the H and L chains
postulated that the WA XId resides on the L chain. Our study, in which we used
the original antisera that defined the WA and BLA XIds and additional polyclo-
nal antisera, presents evidence that the WA and BLA XIds are conformational
antigens requiring both L and H chains, and that with denaturation, the antigens
that define the XId and the antigen-binding activity are lost in parallel.
Volume 164 November 1986
￿
1809-1814
Materials and Methods
BriefDefinitive Report
Preparation of Reagents and Antisera.
￿
IgM mRFs were obtained and isolated as previ-
ously described (2). Antisera used to type the WA XId (anti-McD) and BLA XId (anti-
Bla) were previously described (2). Anti-PSL2, a synthetic peptide corresponding to the
second complementarity-determining region (CDR) and adjacent residues on the L chain
of the IgM RF Sie (8), was provided by Drs. P. P. Chen and D. A. Carson (Scripps Clinic,
LaJolla, CA).
Preparation of H and L Chains.
￿
H and L chains of mRFs were prepared by routine
partial reduction with 10 mM DTT, alkylated and isolated in 1 M propionic acid on a
*100 Sephadex column . Purity of H and L chains was established, and recombination of
H and L chains was performed by mixing H and L chain pools in a 1 :2 M ratio, respectively,
and by dialyzing them for 72 h at 4°C against a 0.5 M Tris, 0 .15 M NaCl buffer (pH
7.2). Recombined H and L chains were isolated with G200 Sephadex column chromatog-
raphy. The recombinant pools were tested for free K or w chains by immunodiffusion in
agarose gel using nonspecific antisera to x and ju chains.
Immunodotting and Blotting.
￿
100 A1 of each mRF diluted to 10 ug/ml in PBS was
"dotted" onto 0.45-gm nitrocellulose paper using a hybridot filtration manifold (Schleicher
& Schuell, Inc., Keene, NH) . Parallel sample sets were stained with Coomassie blue or
blocked with 1 % BSA/PBS and probed with WA or BLA XId-typing reagents. The filter
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FIGURE 1 .
￿
Replica nitrocellulose strips dotted with 1 jAg of Bla mRF, Bla mRF heated (A),
Wa mRF, Wa mRF heated (A), and LaymRF (PO XId group) . Top strip is stained for protein
with Coomassie blue . Second strip is probed with anti-McD, the WA XId typing reagent .
Third strip is probed with anti-Bla, the BLA XId typing reagent . Fourth strip is probed with
anti-PSL2, and the fifth strip is probed with a mixture of anti-rc and antiya.
strips were washed with PBS plus 0.02% BSA and 0.05% Tween 20 (PBT) and were
incubated with 121I-labeled F(ab')2 rabbit anti-goat IgG (5.2 PCi/mg at 106 cpm/ml) for
1 h at 37°C, were washed several times with PBT, and exposed to XAR-5 x-ray film
(Eastman Kodak Co ., Rochester, NY) . The reactivity of anti-McD and anti-Bla with
denatured H and L chains isolated by SDS-PAGE was tested by probing Western blots of
the gel in the same method noted previously for dots .
Direct WA XId Assays.
￿
Wa mRF was coated on microtiter plates (NUNC/Immulon II ;
USA Scientific Plastics Inc ., Ocala, FL) at 0.1 ug/ml in 0.05M Tris (pH 9.5) overnight at
room temperature . Equal volumes of F(ab')2 goat anti-McD at 1 :500 and PBS or inhibitor
were incubated for 1 h at 37 ° C, and 100 A1 ofthe inhibitor or control mixture was added
per well, incubated I h at 37°C, and assayed with alkaline phosphatase-labeled F(ab') 2
rabbit anti-goat IgG H- and L-chain serum (Pel-Freeze Biologicals, Rogers, AR) . The
BLA Id assay was performed in a similar way using a Bla mRF coat (0 .1 kg/ml) and F(ab') 2
goat anti-Bla diluted 1 :10,000 . The same format was used for the IgG-binding assay,
except that human IgG was coated at 10 jug/ml, mRFs were incubated with the coat 1 h
at 37°C and overnight at 4 °C, and peroxidase-labeled F(ab')2 goat anti-human IgM
(1 :500) was used as the second antibody. Direct optical density readings were taken as
measure of binding .
Results
The reactivity of anti-McD, the WA XId typing antiserum, and anti-Bla, the
BLA XId-typing antiserum, as determined by immunoblot assay, is shown in Fig .
1 . The WA XId reagent reacted only with Wa mRF . When heated at 90°C for
20 min, Wa mRF showed no reactivity . Similarly, the BLA XId reagent reacted
only with native Bla . Four other tested mRFs of the WA group, McD, Dri, Blo,
and Gar, lost reactivity with the WA XId reagent when heated at 90°C for 20
min . No other mRFs of the BLA group were available for testing . We also tested
the reactivity of the WA and BLA XId reagents with completely denatured H
and L chains of Bla and Wa mRFs separated on SDS-PAGE . Probes of Western
blots of SDS-PAGE separation of mRFs at 20 times the concentration used in
Fig . 1 showed no positive reactions with K chains and only occasional weak
reactivity of the WA XId reagent with Wa H chains . In contrast to the anti-XId
sera, which did not react with heat-denatured mRF, anti-PSL2 raised against the3
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FIGURE 2.
￿
(A) Inhibition in their respective XId assays of samples of Bla mRF (solid circles)
and Wa mRF (open circles) at I pg/ml heated at various temperatures for 20 min. (B) Duplicates
of each sample run in experiments shown in A tested for binding to IgG Sepharose.
TABLE I
Effect ofAcid Conditions on WA XId
181 1
L chain second hypervariable region (L-CDR2) of Sie, a Wa mRF, and shown to
react with mRFs of the WA XId group but not the PO Xld group (8), reacted
more strongly with both heat-denatured Wa and Bla mRFs. Routine anti-lc and
anti-p, typing sera reacted equally well with both native and denatured mRFs.
Results of further studies of the effect of heat on the WA and BLA XId
antigens are shown in Fig. 2 A. There was a sharp loss of Wa and Bla reactivity
in their respective XId assays beginning at ^"60°C with almost total loss of
reactivity at 70°C. Fig. 2 B shows that antigen-binding activity by Wa and Bla
mRFs appears to be lost over an almost identical temperature range.
Sucrose density gradient ultracentrifugation was performed on the heated
mRFs. With increasing temperature between 60°C and 70°C there was progres-
sive aggregation ofthe 19S IgM mRFs so that at 70'C no monomeric IgM mRF
was detectable.
The effect of three acid conditions commonly used in the preparation of RFs
on the Xld antigens of the Wa and Bla mRFs was tested at 4°C and at room
temperature (25'Q for varying times. The results obtained with Wa mRF are
shown in Table I; results with Bla mRF were similar. The greatest decrease in
Wa XId was caused by 1 N acetic acid. Treatment with pH 2.8 glycine-HCI
caused the smallest loss ofXId antigens.
The requirement ofboth H and L chains for expression ofboth WA and BLA
Xlds was shown by chain recombination experiments (Fig. 3). The reactivity of
Decrease WA Xld (%) after incubation for:
Acid condition 24 h
4°C
48 h 72 h
25°C
72 h
pH 2.8, glycine-HCI 4 6 17 36
pH 4.0, 0.1 N acetic acid 9 11 21 54
pH 2.3, 1.0 N acetic acid 28 34 42 100181 2
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FIGURE 3.
￿
(A) Inhibition in WA XId assay of whole Wa mRF (WA), Way chains (ju), Wa K
chain (rc), and isolated recombinant Wa A and Wa is chain (F+ + a). Concentration of each
preparation giving 50% inhibition is shown at top left corner. (B) Same experiment as shown
in A with use of Bla preparations in BLA XId assay.
the partially reduced u chain as compared with that of the partially reduced is
chain cannot be assessed accurately because antibodies specific for either chain
cannot be excluded. In both the WA and BLA experiments, however, the u
chains showed greater inhibition than the is chains.
Discussion
This study provides evidence that the WA and BLA XIds as originally defined
(1, 2) are present on the native antibody molecules, require both H and L chains,
and are lost with denaturation. These findings also apply to the Bla private Id
since the BLA XId was tested on Bla and not on another rheumatoid factor of
the BLA group. Heating of Bla and Wa mRFs resulted in aggregation. It is
unlikely, however, that loss of reactivity of the XId antisera was due to random
masking of XId determinants because reactivity with other antisera to H and L
chains was unaffected. Anti-PSL2 has been shown to react ^-10 times greater
with denatured isolated L chains than with the intact mRF (8). The increased
reactivity of anti-PSL2 with heated Wa and Bla mRFs indicates loss of native
structure and exposure of hidden primary structures with heating, thus support-
ing the possibility that heating destroys the conformation determinants of the
XId. These findings also indicate that heatingcan differentiate between WA and
BLA XIds determined by conformational antigens and the primary sequence-
dependent XId, PSL2-CRI (5). These experiments also show that PSL2-CRI is
not unique to Wa mRFs since it is present on Bla, the prototype mRF for the
BLA group.
The possibility that the parallel loss of XIds and antigen-binding activities is
coincidental cannot be excluded. Nevertheless, in view of the previous evidence
(2) that antigens determining the BLA and WA XIds are associated with the
antigen-combining sites, it is likely that the XIds are destroyed with heating
along with the antigen-binding activity of the antibodies.
The relatively narrow temperature range over which denaturation of XIds
was seen in our study has not been noted previously. Whether this is a feature
of other Ids remains undetermined. Preliminary studies with polyclonal RI's
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indicate that binding activity diminishes over a similar temperature range (9).
Therefore, heat lability may be a common feature of combining-site Ids of RFs.
Another observation in our study has not been noted previously: denaturation
of RFs under the acid conditions commonly used for their preparation can cause
marked loss ofId antigens.
In view of our data, it is untenable to postulate that PSL2 is the structural
correlate of the WA XId (7). Use ofantisera to primary structures of the CDR
to delineate the structural basis of the WA XId is unlikely to be a productive
approach since this Id is a conformational antigen requiring both H and L chains.
A more promising approach would be assorted chain recombination studies, such
as those used to delineate Ids ofantiarsonate antibodies (10). We did not perform
assorted chain recombination studies, and therefore the relative roles of the K
and,u chains in the formation ofthe WA XId were undetermined. Nevertheless,
results of the limited studies performed suggest that the H rather than the L
chains may play the major role. The role of the KIIIb L chains in the WA XId
may be nonspecific, as previously postulated (4). The XId defined by anti-PSL2
may be totally unrelated to the WA XId or antibody specificity.
Summary
Evidence was obtained that both the WA and BLA crossidiotype (XId) groups
are conformational antigens requiring both L and H chains and that with heat
denaturation the antigens that define the XIds and antigen-binding activity are
lost in parallel. In contrast, the primary structure-dependent crossreactive idi-
otype (CRI), PSL2, which is only weakly detected on native Wa and Bla mono-
clonal rheumatoid factors (mRFs), became prominently detected on the heated
Wa and Bla mRFs. Heat denaturation may provide a simple method for distin-
guishing Ids determined by conformational antigen from primary structure-
dependent Ids. In addition to heat denaturation, some acid conditions commonly
used for preparation ofRFs were also found to cause marked loss ofId antigen.
The finding of PSL2-CRI on Bla mRF indicates that this Id is not unique to the
WA XId.
The authors would like to thank Ms. Patricia Leasure for her excellent technical assistance
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